Wednesday, 19th February 15th Lorne Infection and Immunity 2025

• Immune defense against tuberculosis - Anca Dorhoi

• Phagocytosis, new technologies, receptors, and surprises - David Underhill

• Developing the R21/Matrix-M malaria vaccine - Mehreen Datoo
• SToP (See, Treat, and Prevent) activities for impetigo control in remote Western Australia: a cluster randomised, stepped-wedge Trial - Asha Bowen
• Development of mRNA vaccines for hepatitis C virus - Joey McGregor
• Insights from Immunotherapeutics for Cancer and Autoimmune Diseases: Adapting Approaches for Infectious Diseases - Vasso Apostolopoulos
• Structural characterisation of anti-JEV human antibody epitopes reveals a new target for broad spectrum therapies and vaccines. - Connor Scott
• FECAL MICROBIAL TRANSPLANTATION IN PROTECTION FROM RECURRENT C. DIFFICILE INFECTION - William Petri
• Personalised cell membrane vaccine combined with precision nanomedicine for enhanced immunotherapy  - Li Li

Odd-numbered posters will be presented during this session

• Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine  - Syed Faraz Ahmed
• The overlap between lipid droplets and extracellular vesicles in viral infection - Irumi I Amarasinghe
• PacBio HiFi Sequencing of the entire 16S rRNA gene reveal differences in the oral bacterial communities of healthy men and women infected with oral human papillomavirus infection - Annika Antonsson
• Emerging infectious diseases - Vasso Apostolopoulos
• Investigating disease progression in a large animal model of pulmonary fibrosis - Rob Bischof
• Inhibition of type I interferon signalling during Shigella flexneri infection - Anita A Chaulagain
• Development of vaccines against gonococcal disease using the PilVax platform - Mejo Chiratteparambil Korah
• Identification and characterisation of Cryptosporidium effector proteins in host-pathogen interaction - Lena Chng
• Specific gut microbiota modulates intestinal epithelial cell signalling and inflammation - Michelle Chonwerawong
• Characterisation of novel cytokine interferon epsilon in the murine peritoneal cavity in the context of high-grade serous ovarian cancer - Jasmine Chuah
• Characterising commensal and pathogenic staphylococcal interactions with neonatal and adult blood - Andrew Currie
• Rapid point of care self-test for diagnosis of active syphilis  - Heidi E Drummer
• Inhibitory activity of lactic acid isomers against L. iners and BV-associated vaginal bacteria   - Paula Ellenberg
• MicroRNA sepsis biomarkers: distinguishing bacterial aetiology from non-infectious inflammation in critically ill Australian patients - Ryan J Farr
• Aryl N-acetamides compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1. - Paul Gilson
• Distribution of phenotypic antimicrobial resistance in the gastrointestinal microbiome. - Emily L. Gulliver
• Targeted microbiome remodelling as therapeutic interventions for gastrointestinal diseases - Suet Li Hooi
• Evaluation of antimicrobial and antibiofilm properties of novel synthetic antimicrobial peptides - Taghrid Istivan
• Development of antisense therapeutics for psoriasis - Sulev Koks
• A precision serology evaluation of a Swedish preeclampsia cohort verifies a link between CagA Helicobacter pylori infection and development of preeclampsia  - Soraya Leedham
• Phocaeicola dorei abundance is discriminatory between health and endometriosis in Australian women - Yenkai Lim
• Bacterial membrane vesicles promote horizontal gene transfer in Helicobacter pylori - Christopher McCrory
• Tracing the plasma proteomic and metatranscriptomic response to cladribine treatment in multiple sclerosis. - Sam WZ Olechnowicz
• A new model to test the direct delivery of aerosolised therapeutics to human airway cells – improving treatments for respiratory viruses - Elizabeth A Pharo
• Seasonal antigenic prediction of influenza A H3N2 using machine learning - Ahmed Abdul Quadeer
• Fitness landscape and evolutionary models for combating Hepatitis C virus - Ahmed Abdul Quadeer
• Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data - Ahmed Abdul Quadeer
• Combination of redox modifiers with artemisinin results in increased parasite susceptibility to artemisinins - Annie Roys
• Rabies Disease: Defining antigenic requirements for pan-lyssavirus neutralisation  - Rebecca Shipley

7.30pm Shuttle Bus Departs Lorne Mantra Lobby to Peak Restaurant

7.45pm Dinner at Peak Restaurant

10.00pm Shuttle Bus Departs from Peak Restaurant